{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:26:06Z","timestamp":1763713566967,"version":"3.45.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12185-025-04080-3","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:02:00Z","timestamp":1759582920000},"page":"922-926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of ibrutinib and diagnostic liver biopsy for idiopathic refractory ascites after allogeneic stem cell transplantation"],"prefix":"10.1007","volume":"122","author":[{"given":"Shota","family":"Takahata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-8693","authenticated-orcid":false,"given":"Kazuki","family":"Sakatoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Shiohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirei","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Makuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutaka","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"issue":"8","key":"4080_CR1","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/bmt.2015.105","volume":"50","author":"JT Leonard","year":"2015","unstructured":"Leonard JT, Newell LF, Meyers G, Hayes-Lattin B, Gajewski J, Heitner S, et al. Chronic Gvhd-associated serositis and pericarditis. Bone Marrow Transplant. 2015;50(8):1098\u2013104.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"4080_CR2","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2016.6482","volume":"8","author":"H Hosoi","year":"2016","unstructured":"Hosoi H, Warigaya K, Murata S, Mushino T, Kuriyama K, Nishikawa A, et al. Refractory ascites with liver fibrosis developed in late phase allogeneic hematopoietic stem cell transplantation: report of three patients. Hematol Rep. 2016;8(2):6482.","journal-title":"Hematol Rep"},{"issue":"7","key":"4080_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1182\/bloodadvances.2019000638","volume":"4","author":"A Varma","year":"2020","unstructured":"Varma A, Abraham SC, Mehta RS, Saini NY, Honhar M, Rashid M, et al. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv. 2020;4(7):1296\u2013306.","journal-title":"Blood Adv"},{"issue":"18","key":"4080_CR4","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.2169\/internalmedicine.1139-22","volume":"62","author":"K Tazoe","year":"2023","unstructured":"Tazoe K, Nishimoto M, Yamamoto A, Makuuchi Y, Kuno M, Okamura H, et al. Ibrutinib induces a dramatic improvement for idiopathic refractory ascites following allogeneic hematopoietic cell transplantation. Intern Med. 2023;62(18):2737\u201341.","journal-title":"Intern Med"},{"issue":"9","key":"4080_CR5","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","volume":"24","author":"M Nishida","year":"2018","unstructured":"Nishida M, Kahata K, Hayase E, Shigematsu A, Sato M, Kudo Y, et al. Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018;24(9):1896\u2013900.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"4080_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","volume":"58","author":"M Mohty","year":"2023","unstructured":"Mohty M, Malard F, Alaskar AS, Aljurf M, Arat M, Bader P, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplant. 2023;58(7):749\u201354.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"4080_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology. 1994;19(5):1171\u201381.","journal-title":"Hepatology"},{"issue":"1","key":"4080_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD DeLeve","year":"2002","unstructured":"DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis. 2002;22(1):27\u201342.","journal-title":"Semin Liver Dis"},{"issue":"Suppl 1","key":"4080_CR9","first-page":"S21","volume":"7","author":"KE Matsukuma","year":"2016","unstructured":"Matsukuma KE, Wei D, Sun K, Ramsamooj R, Chen M. Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD). J Gastrointest Oncol. 2016;7(Suppl 1):S21-31.","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"4080_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/sj.bmt.1702997","volume":"27","author":"N Fujii","year":"2001","unstructured":"Fujii N, Takenaka K, Shinagawa K, Ikeda K, Maeda Y, Sunami K, et al. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001;27(9):1007\u201310.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"4080_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959\u201374.","journal-title":"J Hepatol"},{"issue":"4","key":"4080_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993;118(4):255\u201367.","journal-title":"Ann Intern Med"},{"issue":"6","key":"4080_CR13","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44(6):778\u201383.","journal-title":"Transplantation"},{"key":"4080_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110736","volume":"131","author":"ME Shaker","year":"2020","unstructured":"Shaker ME, Gomaa HAM, Alharbi KS, Al-Sanea MM, El-Mesery ME, Hazem SH. Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide\/galactosamine-induced hepatic damage. Biomed Pharmacother. 2020;131:110736.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4080_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/hep.510310316","volume":"31","author":"DI Tai","year":"2000","unstructured":"Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, Sheen IS, et al. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology. 2000;31(3):656\u201364.","journal-title":"Hepatology"},{"issue":"2","key":"4080_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","volume":"8","author":"T Luedde","year":"2011","unstructured":"Luedde T, Schwabe RF. NF-\u03baB in the liver\u2014linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(2):108\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"4080_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.4049\/jimmunol.2001323","volume":"209","author":"B Ye","year":"2022","unstructured":"Ye B, Chen S, Guo H, Zheng W, Lou G, Liang X, et al. The inhibition of Bruton tyrosine kinase alleviates acute liver failure via downregulation of NLRP3 inflammasome. J Immunol. 2022;209(6):1156\u201364.","journal-title":"J Immunol"},{"issue":"5","key":"4080_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/jth.13651","volume":"15","author":"JJ Shatzel","year":"2017","unstructured":"Shatzel JJ, Olson SR, Tao DL, McCarty OJT, Danilov AV, DeLoughery TG. Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies. J Thromb Haemost. 2017;15(5):835\u201347.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"4080_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1182\/blood-2015-03-635326","volume":"126","author":"ML Wang","year":"2015","unstructured":"Wang ML, Blum KA, Martin P, Goy A, Auer R, Kahl BS, et al. Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood. 2015;126(6):739\u201345.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04080-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04080-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04080-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:23:43Z","timestamp":1763713423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04080-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4080"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04080-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.H. received support and financial involvement from Meiji Seika Pharma Co., Ltd. and Janssen Pharmaceutical Ltd. H.N. received support and financial involvement from Meiji Seika Pharma Co., Ltd. and Janssen Pharmaceutical Ltd. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}